Page last updated: 2024-10-28

hexamethonium and Aura

hexamethonium has been researched along with Aura in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yaari, Y1
Jensen, MS1

Other Studies

1 other study available for hexamethonium and Aura

ArticleYear
Cholinergic modulation of hippocampal epileptic activity in vitro.
    EXS, 1989, Volume: 57

    Topics: Acetylcholine; Animals; Atropine; Carbachol; Epilepsy; Hexamethonium; Hexamethonium Compounds; Hippo

1989